Sign in
4

Changes in Ownership

Immunovant, Inc. Filed Acc 0001764013-25-000115

Chief Technology Officer sold 2,805 shares at $18.15 ($50,911)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stout Jay S Chief Technology Officer 2025-07-23 Sale −2,805 $18.15 $50,911 204,919 D
Open-market sales · 2,805 sh · avg $18.15 · $50,911
Loading xslF345X05/wk-form4_1753477896.xml…